Public Company News

Greenland Technologies Schedules 2023 Annual Meeting of Shareholders

EAST WINDSOR, N.J., Dec. 19, 2023 /PRNewswire/ -- Greenland Technologies Holding Corporation (Nasdaq: GTEC) ("Greenland" or the "Company"), a technology developer and manufacturer of electric industrial vehicles and drivetrain systems for material handling machineries and vehicles, today announce...

2023-12-19 21:00 4719

New Drug Application of Mabwell's 8MW0511 for Injection Accepted by NMPA

SHANGHAI, Dec. 19, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that the new drug application of its recombinant (yeast-secreted) human serum albumin-human granulocyte colony-stimulating factor (I) fusion protein for injec...

2023-12-19 20:00 2066

INFOBIRD CO., LTD ANNOUNCES NEW BUSINESS COOPERATION IN INFORMATION TECHNOLOGY SYSTEM SOFTWARE DEVELOPMENT

HONG KONG, Dec. 18, 2023 /PRNewswire/ -- Infobird Co., Ltd (NASDAQ: IFBD) ("Infobird" or the "Company"), a software-as-a-service provider of AI-powered customer engagement solutions inChina, today announced that a new business cooperation in software development of information technology system h...

2023-12-19 06:00 4865

Dexter Studios, a Korean VFX company, presents an iconic VFX visual again on a global stage through 'YuYu Hakusho' as Netflix Original series

* Dexter Studios has added its global portfolio with 'YuYu Hakusho' in Netflix original series by diversifying the artwork concept of comic book characters being in real life * Emphasizing the genre characteristics of action, occult, and fantasies while trying to making it feel real about mag...

2023-12-18 21:00 2779

51Talk Online Education Group Announces Third Quarter 2023 Results

SINGAPORE, Dec. 18, 2023 /PRNewswire/ -- 51Talk Online Education Group ("51Talk" or the "Company") (NYSE American: COE), a global online education platform with core expertise in English education, announced its unaudited results for the third quarter endedSeptember 30, 2023. Third Quarter 2023 ...

2023-12-18 20:00 4928

Neuren Phase 2 trial shows significant improvements in Phelan-McDermid syndrome

Highlights:  * Significant improvement was assessed by both clinicians and caregivers across multiple efficacy measures   * Improvements were consistently seen across clinically important aspects of Phelan-McDermid syndrome, including communication, behaviour, cognition/learning and socialis...

2023-12-18 19:00 1794

GC Biopharma Announces US FDA Approval for ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid for Adults with Primary Humoral Immunodeficiency (PI)

YOGIN, South Korea, Dec. 17, 2023 /PRNewswire/ -- GC Biopharma Corp (006280.KS) today announces that the US Food and Drug Administration (FDA) has approved ALYGLO (immune globulin intravenous, human-stwk) 10% Liquid, formerly referred to as "GC5107," for the treatment of adult patients aged 17...

2023-12-18 09:49 2385

Caliway Closes Oversubscribed Capital Raise and Secures Over $100M to Advance CBL-514 Pivotal Phase 3 Study in Subcutaneous Fat Reduction

TAIPEI, Dec. 16, 2023 /PRNewswire/ -- Caliway Biopharmaceuticals (Caliway) announced that it has closed an oversubscribed capital raise, securing over$100M by issuing 8 million new shares. The new funding will enable Caliway to advance the clinical development of its lead pipeline CBL-514, a sma...

2023-12-16 15:47 2734

Scienjoy Holding Corporation Reports Nine months ended September 30, 2023 Unaudited Financial Results

BEIJING, Dec. 15, 2023 /PRNewswire/ -- Scienjoy Holding Corporation ("Scienjoy", the "Company", or "we") (NASDAQ: SJ), an interactive entertainment leader in the Chinese market, today announced its unaudited financial results for the nine months endedSeptember 30, 2023. Nine Months 2023 Operatin...

2023-12-16 05:30 6973

Lufax Announces Receipt of Notice Regarding NYSE Continued Listing Standards and Effectiveness of its ADS Ratio Change

SHANGHAI, Dec. 15, 2023 /PRNewswire/ -- Lufax Holding Ltd ("Lufax" or the "Company") (NYSE: LU and HKEX: 6623), a leading financial services enabler for small business owners inChina, today announced that it received a letter from the New York Stock Exchange (the "NYSE") datedNovember 30, 2023, n...

2023-12-16 05:30 6884

Appointment of New Independent Director

NEW YORK, Dec. 15, 2023 /PRNewswire/ -- Fresh2 Group Ltd. (NASDAQ: FRES) ("Fresh2" or "the Company"), a B2B e-commerce and supply chain management company within the restaurant and food industry, today announced the appointment ofZhijun (Michael) Liang, as an independent director of the Company,...

2023-12-16 05:01 2989

World's First and Largest Tower Crane Receives Recognition from 11 Industry Experts in Technical Appraisal

XUZHOU, China, Dec. 15, 2023 /PRNewswire/ -- The XGT15000-600S, the world's largest tower crane with the biggest double-boom parallel combination that is jointly developed by XCMG Machinery (SHE: 000425, "XCMG") and China Railway Major Bridge Engineering Co., Ltd. ("MBEC"), has recently been reco...

2023-12-16 01:46 5012

RING IN THE HOLIDAYS WITH PARAGON: THE OVERPRIME'S SECOND PLAYSTATION 5 CLOSED BETA TEST

LOS ANGELES, Dec. 15, 2023 /PRNewswire/ -- Netmarble, a leading developer and publisher of high-quality video games, announces the start of the second Closed Beta Test (CBT) forPARAGON: THE OVERPRIME on PlayStation 5. The CBT starts today throughJanuary 8 in the United States, Europe, and Russia....

2023-12-16 01:00 3623

Lixiang Education Announces Plan to Implement ADS Ratio Change

LISHUI, China, Dec. 15, 2023 /PRNewswire/ -- Lixiang Education Holding Co., Ltd. (the "Company" or NASDAQ: LXEH), a prestigious private education service provider inChina, today announced that it plans to change the ratio of its American depositary shares ("ADSs") to its ordinary shares (the "ADS...

2023-12-15 22:15 5758

KFC China Celebrates the Opening of its 10,000th Store

-       Milestone Store Opening Underscores KFC's Continued Success as the Leading Restaurant Brand inChina -       KFC China's Ambitious Growth Trajectory: Targeting Over Half of China's Population by 2026 SHANGHAI, Dec. 15, 2023 /PRNewswire/ -- Yum China Holdings, Inc. (NYSE: YUMC and HKEX: 9...

2023-12-15 22:00 7472

Akeso Published Results from CD47 Antibody Ligufalimab in Combination with Azacitidine for Newly Diagnosed Higher-Risk Myelodysplastic Syndrome and Treatment-naïve Acute Myeloid Leukemia at ASH 2023

HONG KONG, Dec. 15, 2023 /PRNewswire/ -- Akeso published two phase Ib clinical results of its innovative CD47 monoclonal antibody ligufalimab (AK117) in combination with azacitidine in patients with newly diagnosed higher-risk myelodysplastic syndrome (HR-MDS) and treatment-naïve acute myeloid le...

2023-12-15 21:00 2586

Ucommune Regains Compliance with Nasdaq Minimum Bid Price Requirement

BEIJING, Dec. 15, 2023 /PRNewswire/ -- Ucommune International Ltd (NASDAQ: UK) ("Ucommune" or the "Company"), an office space manager and provider inChina, today announced that it received a notification letter (the "Notification Letter on Compliance") from the Listing Qualifications Department o...

2023-12-15 19:30 5628

ZKH Group Limited Announces Pricing of Initial Public Offering

SHANGHAI, Dec. 15, 2023 /PRNewswire/ -- ZKH Group Limited ("ZKH" or the "Company") (NYSE: ZKH), a leading maintenance, repair and operations ("MRO") procurement service platform inChina, today announced the pricing of its initial public offering of 4,000,000 American depositary shares ("ADSs"), a...

2023-12-15 18:00 5297

Appotronics ALPD® cinema laser light source highlight CineAsia 2023

SHENZHEN, China, Dec. 15, 2023 /PRNewswire/ -- As the largest and most influential film and television equipment exhibition inAsia, CineAsia 2023 was held at the True Icon Hall inBangkok, Thailand from December 5 to 7, 2013. Appotronics Corporation Ltd., (Appotronics), the global leader in cinema...

2023-12-15 16:30 2575

Live from ASH 2023 | Oral Report Featuring Encouraging Data of Olverembatinib Combined with Reduced-Intensity Chemotherapy in Patients with Ph+ ALL Presented at the ASH Annual Meeting

SUZHOU, China and ROCKVILLE, Md., Dec. 14, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today thatProf. Xiaoyuan Gong of the Institute of Hemato...

2023-12-15 11:14 2705
1 ... 322323324325326327328 ... 772